MEDBOX | Toolbox HIV

	HIV drug resistance surveillance in countries scaling up pre-exposure prophylaxis World Health Organization WHO (2020) C_WHO View PDF(25) Download (26) Add to my MEDBOX WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches. HIV drug resistance has been rarely reported among PrEP users who tested HIV positive in randomized controlled trials or open-label studies. However, PrEP-selected HIV drug resistance could potentially negatively impact the effectiveness of treatment options among PrEP users who acquire HIV, since there is a potential for overlapping resistance profiles between antiretroviral drugs used for both PrEP and first-line antiretroviral therapy Tags: HIV, Surveillance, Drug Resistance, update, hiv surveillance, PEP, PrEP, Source: https://apps.who.int/iris/rest/bitstream
	Consolidated guidelines on HIV testing services World Health Organization WHO (2020) C_WHO View PDF(646) Download (442) Add to my MEDBOX These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations. The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in response to requests from Member States, national programme managers and health workers for support to achieve the United Nations (UN) 90–90–90 global HIV targets – and specifically the first target of diagnosing 90% of all people with HIV. In 2016, based on new evidence, WHO released a supplement to address important new HIV testing approaches – HIV self-testing (HIVST) and provider-assisted referral. Since the release of 2015 and 2016 HTS guidelines, new issues and more evidence have emerged. To address this, WHO has updated guidance on HIV testing services. In this guideline, WHO updates recommendation on HIVST and provides new recommendations on social network-based HIV testing approaches and western blotting (see box, next page). This guideline seeks to provide support to Member States, programme managers, health workers and other stakeholders seeking to achieve national and international goals to end the HIV epidemic as a public health threat by 2030. These guidelines also provide operational guidance on HTS demand creation and messaging; implementation considerations for priority populations; HIV testing strategies for diagnosis HIV; optimizing the use of dual HIV/syphilis rapid diagnostic tests; and considerations for strategic planning and rationalizing resources such as optimal time points for maternal retestin Tags: hiv, Testing, voluntary counselling and testing, Source: https:/https://www.afro.who.int/sites/de
	COVID-19 and HIV: 1 moment, 2 epidemics, 3 opportunities UNAIDS (2020) C_WHO View PDF(0) Download (0) Add to my MEDBOX how to seize the moment to learn, leverage and build a new way forward for everyone’s health and rights This new report by UNAIDS examines how the experience of tackling HIV can help inform and guide effective, efficient, people-centred and sustainable COVID-19 responses Tags: stigma, discrimination, hiv, COVID-19, communication, response, Source: https://www.unaids.org/sites/default/fil
	Addressing stigma and discrimination in the COVID-19 response UNAIDS (2020) C_WHO View PDF(1) Download (0) Add to my MEDBOX Applying the evidence of what works from HIV-related stigma and discrimination in six settings to the COVID-19 response This brief provide evidence-informed guidance to countries on the intersection of stigma related to HIV and COVID-19 in national responses Tags: stigma, discrimination, COVID-19, HIV, Source: https://www.unaids.org/sites/default/fil
	WHO/HIVRESNET HIV drug resistance - laboratory operational framework World Health Organization WHO (2020) C_WHO View PDF(34) Download (31) Add to my MEDBOX The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable results at the national, regional and global levels. This publication updates the WHO HIVResNet HIV drug resistance laboratory operational framework published in 2017 and reflects technical and strategic developments over the past three years Tags: laboratory, HIV, Drug Resistance, guideline, Source: https://apps.who.int/iris/rest/bitstream
	Global Tuberculosis Report 2020 World Health Organization WHO (2020) C_WHO View PDF(171) Download (56) Add to my MEDBOX TB remains the top infectious killer in the world claiming close to 4000 lives a day. Millions of people continue to fall ill with TB- a preventable and curable disease each year. The Global TB Report 2020 provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels in the context of global commitments and strategies. The report features data on disease trends and the response to the epidemic in 198 countries and territories. This includes trends in TB incidence and mortality, data on case detection and treatment results for TB, multidrug-resistant TB (MDR-TB), TB/HIV, TB prevention, universal health coverage as well as financing. Also included is an overview of pipelines for new TB diagnostics, drugs and vaccine Tags: global data, report, tb, tb country data, TB incidence, TB mortality, TB/HIV, MDR-TB, Tb policies, Source: https://www.who.int/publications/i/item/
	COVID-19’s impact on HIV vertical transmission services reversed UNAIDS (2020) C_WHO View PDF(0) Download (0) Add to my MEDBOX Tags: vertical transmission/PMTCT, HIV, COVID-19, hiv service delivery, Source: https://www.unaids.org/en/resources/pres
	HIV-Associated Tuberculosis World Health Organization (WHO) World Health Organization (WHO) (2020) C_WHO View PDF(33) Download (34) Add to my MEDBOX Accessed:10.03.2020 Tags: HIV, TB, co-infection, Epidemiology, TB/HIV, HIV/TB, Source: https://www.who.int/tb/areas-of-work/tb-
	COVID-19 and HIV: Moment, Epidemics, Opportunities UNAIDS (2020) CC View PDF(4) Download (2) Add to my MEDBOX The COVID-19 pandemic has exposed the inadequacy of investments in public health, the persistence of profound economic and social inequalities and the fragility of many key global systems and approaches Tags: COVID-19, HIV/AIDS, pandemic, Lessons learned, Source: https://reliefweb.int/sites/reliefweb.in
	UNAIDS calls on governments to strengthen HIV-sensitive social protection responses to the COVID-19 pandemic UNAIDS (2020) C_WHO View PDF(6) Download (6) Add to my MEDBOX UNAIDS calls on governments to live up to their commitment to develop nationally owned and led social protection systems for all, including floors; and scale up and progressively enhance coverage, adequacy and comprehensiveness, thereby improving the responsiveness and quality of interventions to address the needs and vulnerabilities of people living with HIV Tags: humanitarian aid, humanitarian settings, HIV, vulnerable people, COVID-19, social protection, Source: https://www.unaids.org/sites/default/fil

About MEDBOX